JFK Code

General

The HIBC "Provider Applications" Standard is applicable to pharmaceutical labelling in a closed system.

Labeller identification

Because there is only "one pharmaceutical" labeller within a closed system, this labeller will not be further identified in the bar coding than by the 'source' identification.

For uniform identification of the article concerned, there is always a reference to the Z-index drug data base in the closed system for pharmaceutical products. Products which are collected in this data base are identified by the HPK number.

It concerns the following products. First, generic drugs prepared by the pharmacy according to the FNA standard (Formularium der Nederlandse Apothekers, a standard method for preparing drugs).

Secondly, the giving out in appropriate quantities of drugs which have already been prepared.

The remaining drugs, namely generic drugs prepared by the pharmacy not according to the FNA, are given an indicated standard of '9 numbers' in accordance with the Z-index drug data base.

It is recommended that these last mentioned drugs will eventually be collected in the Z-index drug data base in order to come to a balanced quality assurance at a national level. It is signalled perhaps unnecessarily that drugs which are manufactured for administration outside the closed system, should be encoded according to the HIBC Supplier Labeling Standard.
Thus, they should be labelled with a LIC number. For that purpose, the labeller (pharmacy) concerned should have a unique LIC number at his disposal.

Data structure for product identification

The letter 'J' is the 'where flag' for drugs. This indicates, in accordance with the Provider Applications Standard, that the data is stored in a 'product container'.

The letter 'F' is the 'what kind of data' indicator. This indicates, in accordance with the Provider Applications Standard, that it concerns a 'product which has to be administered to a patient'.

The third character identifies the source within the closed system. This is the letter 'K' for the source 'pharmacy'. This letter also implies that the product identification is in accordance with the Z-index drug data base.

Within the closed system, further agreements should be reached on, among others, 'source identification'; i.e. another source than the pharmacy.

The data structure for pharmaceutical application is, then, defined as follows:

* J F K a b c d C *

* - Start and Stop Code

J - Product Container

F - Product which has to be administered to a patient

K - Container Source Indication, in this case 'Pharmacy'

abcd - Z-index HPK Code, modulo 36

C - Modulo 43 Check Character